Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 12  •  11:51AM ET
80.91
Dollar change
-52.23
Percentage change
-39.23
%
Today, 9:55 AMBofA and Leerink downgraded Icon Plc to Underperform and Market Perform, respectively, slashing price targets to $75 and $105 following the company’s disclosure of a board-led accounting investigation and potential 2023-2024 revenue overstatements.
Index- P/E10.94 EPS (ttm)7.40 Insider Own0.78% Shs Outstand76.36M Perf Week-44.35%
Market Cap6.18B Forward P/E6.22 EPS next Y13.00 Insider Trans0.00% Shs Float75.76M Perf Month-55.86%
Enterprise Value9.28B PEG10.20 EPS next Q3.30 Inst Own100.86% Short Float3.73% Perf Quarter-50.49%
Income599.48M P/S0.76 EPS this Y-6.68% Inst Trans-5.81% Short Ratio2.79 Perf Half Y-54.10%
Sales8.10B P/B0.66 EPS next Y-0.47% ROA3.56% Short Interest2.82M Perf YTD-55.60%
Book/sh122.25 P/C13.18 EPS next 5Y0.61% ROE6.27% 52W High211.00 -61.65% Perf Year-56.62%
Cash/sh6.14 P/FCF6.36 EPS past 3/5Y61.03% 6.54% ROIC4.86% 52W Low125.10 -35.32% Perf 3Y-65.17%
Dividend Est.- EV/EBITDA5.72 Sales past 3/5Y14.75% 24.17% Gross Margin23.27% Volatility8.72% 4.93% Perf 5Y-61.57%
Dividend TTM- EV/Sales1.15 EPS Y/Y TTM-17.89% Oper. Margin13.99% ATR (14)13.03 Perf 10Y21.16%
Dividend Ex-Date- Quick Ratio1.06 Sales Y/Y TTM-2.46% Profit Margin7.40% RSI (14)13.64 Recom2.25
Dividend Gr. 3/5Y- - Current Ratio1.06 EPS Q/Q-98.72% SMA20-51.65% Beta1.31 Target Price179.62
Payout0.00% Debt/Eq0.38 Sales Q/Q0.63% SMA50-54.54% Rel Volume36.58 Prev Close133.14
Employees41900 LT Debt/Eq0.32 EarningsOct 22 AMC SMA200-51.17% Avg Volume1.01M Price80.91
IPOMay 15, 1998 Option/ShortYes / Yes EPS/Sales Surpr.0.28% 3.03% Trades Volume14,557,915 Change-39.23%
Date Action Analyst Rating Change Price Target Change
TodayDowngrade Leerink Partners Outperform → Market Perform $105
TodayDowngrade BofA Securities Neutral → Underperform $75
Jan-08-26Downgrade Truist Buy → Hold $222
Dec-15-25Downgrade BofA Securities Buy → Neutral $195
Nov-13-25Initiated BMO Capital Markets Market Perform $175
Sep-09-25Downgrade Jefferies Buy → Hold $175
Sep-03-25Upgrade Rothschild & Co Redburn Neutral → Buy $236
Aug-21-25Downgrade Citigroup Buy → Neutral $200
Jul-24-25Upgrade Robert W. Baird Neutral → Outperform $224
Apr-29-25Downgrade JP Morgan Overweight → Neutral $150
Today 11:10AM
09:44AM
09:02AM
07:38AM
Feb-11-26 10:00AM
07:23PM Loading…
Feb-05-26 07:23PM
Jan-27-26 07:15AM
Jan-22-26 12:06AM
Jan-05-26 07:27AM
Dec-17-25 08:53AM
Dec-10-25 10:31AM
Dec-09-25 07:46AM
07:15AM
Dec-02-25 07:15AM
Nov-27-25 11:30AM
06:27PM Loading…
Nov-26-25 06:27PM
Nov-25-25 07:46AM
Nov-21-25 11:30AM
Nov-13-25 09:11AM
Nov-12-25 06:45AM
Nov-06-25 07:28PM
Oct-24-25 06:41PM
Oct-23-25 11:15AM
Oct-22-25 05:45PM
04:25PM
Oct-20-25 10:00AM
Oct-15-25 10:00AM
Oct-01-25 06:48PM
Sep-26-25 08:52AM
Sep-14-25 01:17AM
12:11PM Loading…
Sep-09-25 12:11PM
Sep-04-25 08:00AM
Sep-02-25 06:00AM
Sep-01-25 12:20PM
Aug-18-25 06:45PM
Aug-12-25 11:41PM
08:54AM
Aug-11-25 07:50AM
Aug-06-25 06:42PM
Jul-25-25 09:45PM
Jul-24-25 06:37PM
Jul-23-25 05:50PM
04:20PM
04:15PM
Jul-17-25 10:00AM
Jul-16-25 10:00AM
07:15AM
Jul-15-25 09:32AM
Jul-07-25 07:15AM
07:06AM
Jul-03-25 10:13AM
Jun-27-25 09:15AM
Jun-23-25 06:30AM
Jun-02-25 10:23AM
04:12AM
May-30-25 11:31AM
May-27-25 08:30AM
May-19-25 04:15PM
May-14-25 07:52AM
May-09-25 03:13AM
May-07-25 12:55PM
07:27AM
May-02-25 09:00PM
03:01AM
02:42AM
May-01-25 06:43PM
09:16AM
Apr-30-25 06:15PM
05:23PM
04:15PM
Apr-29-25 09:12AM
Apr-27-25 04:19PM
Apr-24-25 10:01AM
Apr-23-25 10:01AM
Apr-22-25 07:20AM
Apr-10-25 09:26AM
08:55AM
Apr-09-25 07:10AM
Apr-08-25 06:58AM
Apr-03-25 06:13PM
12:35PM
10:03AM
Apr-02-25 08:00AM
06:00AM
Mar-31-25 06:30AM
03:15AM
Mar-28-25 05:45AM
Mar-27-25 11:50PM
Mar-25-25 10:45AM
Mar-24-25 10:46PM
10:15PM
05:09PM
12:34PM
Mar-23-25 06:05PM
Mar-21-25 11:30AM
Mar-20-25 11:15AM
05:35AM
05:15AM
04:00AM
Mar-19-25 09:05AM
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NIGEL CLERKINOfficerNov 03 '25Proposed Sale169.241,473249,289Nov 03 04:23 PM
STEPHEN CUTLEROfficerOct 02 '25Proposed Sale190.1918,9013,594,781Oct 02 04:03 PM
BARRY EDWARD BALFEOfficerAug 08 '25Proposed Sale157.4638159,993Aug 08 04:33 PM
THOMAS NOEL O'LEARYOfficerAug 08 '25Proposed Sale157.461,136178,877Aug 08 04:27 PM
RONAN MARTIN MURPHYOfficerMay 23 '25Proposed Sale126.9033442,384May 23 04:38 PM
EUGENE PACELLI MCCAGUEOfficerMay 23 '25Proposed Sale126.9033442,384May 23 04:35 PM
LINDA SUE GRAISOfficerMay 23 '25Proposed Sale126.9033442,384May 23 04:32 PM
JOHN CLIMAXOfficerMay 23 '25Proposed Sale126.9033442,384May 23 04:27 PM
JULIE ANN ONEILLOfficerMay 23 '25Proposed Sale126.9036346,065May 23 04:25 PM
CIARAN MURRAYOfficerMay 23 '25Proposed Sale126.9049462,688May 23 04:23 PM
RONAN MARTIN MURPHYOfficerMay 19 '25Proposed Sale130.041,539200,131May 19 04:58 PM
JOHN CLIMAXOfficerMay 19 '25Proposed Sale130.047,6931,000,422May 19 04:30 PM
Dr. John ClimaxDirectorMay 06 '25Proposed Sale143.02140,00020,022,800May 06 05:00 PM
RONAN MARTIN MURPHYOfficerMar 17 '25Proposed Sale187.071,540288,082Mar 17 04:33 PM
THOMAS NOEL O LEARYOfficerMar 04 '25Proposed Sale182.43796145,214Mar 04 05:24 PM
DIARMAID CUNNINGHAMOfficerMar 04 '25Proposed Sale182.431,185216,180Mar 04 05:23 PM
BARRY EDWARD BALFEOfficerMar 04 '25Proposed Sale182.431,216221,835Mar 04 05:20 PM
STEPHEN CUTLEROfficerMar 04 '25Proposed Sale182.435,4961,002,635Mar 04 05:18 PM